98%
921
2 minutes
20
The escalating threat of widespread exposure to environmental pollutants on human health has drawn increasing attention, particularly regarding mycotoxin contaminants with potent carcinogenic properties. As a prototypical environmental toxin, the molecular mechanisms underlying aflatoxin B1-induced gastric carcinogenesis remain poorly defined. This study systematically elucidates the molecular network through which aflatoxin B1 (AFB1) synergistically drives the malignant progression of gastric cancer by specifically targeting five core regulatory genes, exemplified by its upregulation of cyclin genes CCNE1 and CCNE2. Molecular docking simulations demonstrate significant binding activity between AFB1 and the core targets, with MAPK3 exhibiting the optimal binding affinity as evidenced by the most favorable binding free energy. Integrated single-cell RNA sequencing of human gastric cancer tissues and spatial transcriptomics (10X Visium) revealed cell-type-specific expression patterns of these core target genes within immune cell clusters in the tumor microenvironment, particularly in T cell subpopulations. Innovatively, this study constructs a multi-layered molecular regulatory map of AFB1-induced gastric carcinogenesis, establishing a novel paradigm for multi-omics integration in elucidating the toxicological mechanisms of environmental carcinogens.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ecoenv.2025.118919 | DOI Listing |
Appl Biochem Biotechnol
September 2025
Operating Room, Shanghai Tianyou Hospital, No.528, Zhennan Road, Putuo District, Shanghai, 200331, China.
Gastric cancer (GC) is a malignant tumor originating from the epithelial cells of the gastric mucosa. The 5-methylcytosine (mC) modification refers to the addition of a methyl group to the fifth carbon atom of cytosine in RNA molecules. This study aimed to investigate the role of NOL1/NOP2/SUN domain (NSUN)6 in GC and its underlying molecular mechanisms.
View Article and Find Full Text PDFGastric Cancer
September 2025
Department of Gastroenterological Surgery, Hyogo Medical University, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.
Int J Surg
September 2025
The Japanese Society of Gastroenterological Surgery, Tokyo, Japan.
Background: The association between preoperative liver function and short-term outcomes after gastrointestinal cancer surgery is unknown. This study investigated the impact of Child-Pugh score-based preoperative liver dysfunction on short-term outcomes after distal gastrectomy and right hemicolectomy.
Materials And Methods: We included patients who underwent distal gastrectomy for gastric cancer or right hemicolectomy for colon cancer between 2018 and 2022 from the Japanese National Clinical Database.
ANZ J Surg
September 2025
School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Front Genet
August 2025
Department of Gastrointestinal and Hernia Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
Background: Gastric cancer (GC) is a leading cause of cancer-related mortality; however, biomarkers predicting its immunotherapy resistance remain scarce. Vascular cell adhesion molecule ()-, an immune cell adhesion mediator, is implicated in tumor progression; however, its prognostic and immunomodulatory roles in GC remain unclear.
Methods: In this study, we analyzed expression and its clinical relevance in GC using RNA-sequencing data from The Cancer Genome Atlas.